Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RT0028
Target Gene : BRCA2 Host Cell : DLD-1
Size : >1x106 cells/vial Validation : Sequencing
| Cat. No. | CSC-RT0028 |
| Description | DLD-1-BRCA2 (+/-) is a cell line with a heterozygous knockout of human BRCA2 |
| Target Gene | BRCA2 |
| Host Cell | DLD-1 |
| Host Cell Species | Homo sapiens (Human) |
| Size | >1x106 cells/vial |
| Validation | Sequencing |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | BRCA2 breast cancer 2, early onset [ Homo sapiens ] |
| Gene Symbol | BRCA2 |
| Synonyms | FAD; FACD; FAD1; GLM3; BRCC2; FANCB; FANCD; PNCA2; FANCD1; BROVCA2 |
| Gene Description | breast cancer 2, early onset |
| Gene ID | 675 |
| Uni Prot ID | P51587 |
| m RNA Refseq | NM_000059.3 |
| Protein Refseq | NP_000050.2 |
| Chromosome Location | 13q12.3 |
| Function | H3 histone acetyltransferase activity; H4 histone acetyltransferase activity; gamma-tubulin binding; NOT histone acetyltransferase activity; protease binding; protein binding; single-stranded DNA binding; |
| Pathway | DNA Repair, organism-specific biosystem; Double-Strand Break Repair, organism-specific biosystem; FOXM1 transcription factor network, organism-specific biosystem; Fanconi Anemia pathway, organism-specific biosystem; Fanconi anemia pathway, organism-specific biosystem; Fanconi anemia pathway, conserved biosystem; Homologous DNA pairing and strand exchange, organism-specific biosystem; |
| MIM | 600185 |
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
A: Single clonal cell.
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
A: The cell line should be stored in liquid nitrogen for long-term preservation.
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Research BRCA2 gene, this product can perfectly knock out human BRCA2 gene, high efficiency and low cost
Samples can be tested in a variety of simple experiments, greatly speeding up the process.
This product is easy to handle and requires essentially no fuss, but its results are very clear and very convincing.
This product is easy to handle and requires essentially no fuss, but its results are very clear and very convincing.
This transfection was more successful than the previous experimental materials, and I couldn't help but feel that this reagent was so amazing, and my experimental process was one step faster.
In this product, gene knockout is such a simple thing, and the results of repeated experimental experiments are also very clear.
In my follow-up experiments, there will also be gene knockout experiments, I will give priority to this brand of transfection reagent, there is a first surprise, I want to have the next time.
I'm so proud of my experimental results, and I think the knockout transfection reagent I used is a big contribution.
This is not the first time I have used this brand's products, and the second time I have used it, the effect is still very strong.
Having used trial packs of other reagents from this company before, this is the first time I ordered a gene knockout reagent, and it worked very well.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.